Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis

Acta Diabetologica

Volumn 51, Issue 3, 2014, Pages 455-460

  Petit, Jean Michel ^a,b,c,d   Hamza, Samia ^a,b,c   Rollot, Fabien ^a   Sigonney, Vanessa ^b   Crevisy, Elodie ^b   Duvillard, Laurence ^a,b,c   Raab, Jean Jacques ^e   Bronowicki, Jean Pierre ^f   Bernard Chabert, Brigitte ^g   Di Martino, Vincent ^h   Doffoel, Michel ⁱ   Barraud, Helene ^f   Richou, Carine ^h   Jouve, Jean Louis ^a   Hillon, Patrick ^a,b,c  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b Chu   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

^d HÔPITAL DU BOCAGE   (France)

^e Department of Cardiology   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g REIMS UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Alcoholic liver disease; Cirrhosis; Diabetes mellitus; Non alcoholic fatty liver disease; Viral hepatitis

Indexed keywords

ALCOHOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IRON; METFORMIN; SULFONYLUREA;

AGE; AGE DISTRIBUTION; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FAMILY HISTORY; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; VENOUS BLOOD; ADULT; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; FRANCE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FRANCE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84905379129     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0538-y     Document Type: Article

References (15)

1. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H (2009) Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 21(15):280-288
2. Nielsen MF, Caumo A, Aagaard NK, Chandramouli V, Schumann WC, Landau BR, Schmitz O, Vilstrup H, Nielsen MF (2005) Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol 288:G1135-G1143 (Pubitemid 40741065)
3. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL (2008) Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47:1856-1862 (Pubitemid 351945553)
4. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P (2001) Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 35:279-283 (Pubitemid 32803485)
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430 (Pubitemid 32844200)
6. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH (2005) Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 32:209-217 (Pubitemid 30093899)
7. Wlazlo N, Beijers HJ, Schoon EJ, Sauerwein HP, Stehouwer CD (2010) High prevalence of diabetes mellitus in patients with liver cirrhosis. Diabet Med 27:1308-1311
8. Howard AA, Arnsten JH, Gourevitch MN (2004) Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Inter Med 140:211-219
9. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533-539 (Pubitemid 40403031)
10. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N (2003) Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38:1384-1392 (Pubitemid 37466964)
11. Kotronen A, Yki-Järvinen H (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:27-38
12. Arase Y, Kobayashi M, Suzuki F, Suzuki Y, Kawamura Y, Akuta N, Kobayashi M, Sezaki H, Saito S, Hosaka T, Ikeda K, Kumada H, Kobayashi T (2013) Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology 57:964-973
13. Tseng CH (2013) Diabetes is not an independent risk factor for hepatocellular carcinoma. Diabetes Metab Res Rev 29:515-524
14. Wang KL, Liu CJ, Chao TF, Huang CM, Wu CH, Chen SJ, Chen TJ, Lin SJ, Chiang CE (2012) Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol 60:1231-1238
15. Marchesini G, Ronchi M, Forlani G, Bugianesi E, Bianchi G, Fabbri A, Zoli M, Melchionda N (1999) Cardiovascular disease in cirrhosis - a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 94:655-662 (Pubitemid 29124862)